The Rotherham NHS Foundation Trust operates Rotherham General Hospital in South Yorkshire, England. It was previously Rotherham General Hospitals NHS Trust before becoming an NHS Foundation Trust in 2005.

During the past decade, The Rotherham NHS Foundation Trust conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Rotherham NHS Foundation Trust" #1 sponsor was "Abbott Diabetes Care" with 2 trials, followed by "University Hospitals of Derby and Burton NHS Foundation Trust" with 2 trials sponsored, "Cardiff and Vale University Health Board" with 1 trials sponsored, "Hôpital Armand Trousseau" with 1 trials sponsored and "Leeds Cancer Centre at St. James's University Hospital" with 1 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Rotherham NHS Foundation Trust" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator, "Berry Consultants" with 1 trials as a collaborator, "Breast Cancer Trials, Australia and New Zealand" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "The Rotherham NHS Foundation Trust" are "Breast Cancer" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Coronary Syndromes" (1 trials), "Analgesia" (1 trials) and "Anxiety" (1 trials). Many other conditions were trialed in "The Rotherham NHS Foundation Trust" in a lesser frequency.

Most popular intervention types in "The Rotherham NHS Foundation Trust" are "Drug" (8 trials), "Procedure" (6 trials), "Device" (5 trials), "Other" (5 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Simvastatin" (2 trials), "quality-of-life assessment" (2 trials), "ARB + DMX-200" (1 trials) and "Active VITATOPS Tablet (folic acid 2mg, B6 25mg , B12 500ug) or placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Rotherham NHS Foundation Trust" are 20 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "The Rotherham NHS Foundation Trust". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in The Rotherham NHS Foundation Trust, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Rotherham NHS Foundation Trust, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".